Table 5.
Study | Clearly stated aim | Inclusion of consecutive patients | Prospective collection of data | Endpoints appropriate to study aim | Unbiased assessment of study endpoint | Follow-up period appropriate to study aim | Loss to follow-up < 5% | Prospective calculation of study size | Total quality score |
---|---|---|---|---|---|---|---|---|---|
Abdul-Rahman et al. (2009) [23] | 1 | 0 | 0 | 1 | 0 | 1 | 2 | 0 | 4 |
Al-Qudah (2006) [24] | 1 | 2 | 0 | 2 | 0 | 0 | 2 | 0 | 7 |
Ciriaco et al. (2009) [14] | 1 | 2 | 0 | 2 | 0 | 2 | 2 | 0 | 9 |
Divisi et al. (2011) [7] | 2 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 4 |
Ergene et al. (2013) [25] | 1 | 0 | 0 | 1 | 0 | 0 | 2 | 0 | 5 |
Gloyer et al. (2011) [12] | 2 | 0 | 0 | 1 | 0 | 2 | 2 | 0 | 8 |
Kälicke et al. (2006) [5] | 0 | 0 | 0 | 1 | 0 | 2 | 2 | 0 | 5 |
Krinner et al. (2017) [2] | 1 | 0 | 0 | 1 | 0 | 2 | 2 | 0 | 7 |
Labbe et al. (2009) [13] | 1 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 3 |
Nazerali et al. (2014) [18] | 2 | 0 | 1 | 2 | 0 | 2 | 2 | 0 | 9 |
Queitsch et al. (2011) [20] | 2 | 2 | 2 | 2 | 0 | 0 | 2 | 0 | 10 |
Richardson et al. (2007) [26] | 1 | 0 | 0 | 2 | 0 | 1 | 2 | 0 | 6 |
Schulz-Drost et al. (2014) [27] | 2 | 0 | 0 | 2 | 0 | 2 | 2 | 0 | 8 |
Schulz-Drost et al. (2016) [8] | 1 | 0 | 0 | 2 | 0 | 2 | 2 | 0 | 7 |
Wu et al. (2004) [21] | 1 | 0 | 0 | 2 | 0 | 2 | 2 | 0 | 7 |
Zhao et al. (2017) [1] | 2 | 0 | 0 | 2 | 0 | 2 | 2 | 0 | 8 |
Mean quality score (range) | 1.3 (0–2) | 0.4 (0–2) | 0.2 (0–2) | 1.6 (1–2) | 0 (0) | 1.3 (0–2) | 1.8 (0–2) | 0 (0) | 6.7 (3–10) |
0 not reported, 1 reported but inadequate, 2 reported and adequate